recent revid confirm mutant isocitr dehydrogenase id gene occur early gliomagenesi contribute suppress immune present studi aim determine candid gene assoc status could serv biomass immune suppress improv prognosis predict clinic inform nase express data collect lima sample cgi tca database different express lowergrad log glioblastoma gb identify accord one interferonstimul exonucleas is reduce mutant tumor demons signifies provost value level significantly increase increase tumor grade high poor outcome more infiltr monocytederiv macrophages neutrophil adapt response also post correct pd pdl cola along level sever chemin conclude use biomass identify idhmedi process may potent therapeutic target 